Belite Bio (BLTE) Tops Q1 EPS by 10c

Belite Bio (NASDAQ: BLTE) reported Q1 EPS of ($0.27), $0.10 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Morgan Stanley Upgrades Sonova Holding AG (SOON:SW) (SONVY) to Equalweight
• Increasing unusual option volume: UTHR DOMO IHI XIFR ALKS AM CTSH GDS DFTX